Literature DB >> 9166475

Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.

L Schmidt1, F Li, R S Brown, S Berg, F Chen, M H Wei, K Tory, I Lerman, B Zbar.   

Abstract

PURPOSE: Members of a family carrying a constitutional balanced translocation [t(3;8) (p14;q24)] have a high risk of developing multiple, bilateral clear-cell renal carcinomas. Two genetic mechanisms of carcinogenesis for this malignancy have been proposed: (1) disruption of a gene at the translocation breakpoint and (2) mutation of the von Hippel-Lindau tumor-suppressor gene at 3p25. This study further evaluates the role of the von Hippel-Lindau gene in the etiology and pathogenesis of t(3;8)-associated renal carcinomas.
METHODS: Two new t(3;8)-associated renal carcinomas were tested for mutations in the von Hippel-Lindau gene by single-stranded conformational polymorphism analysis followed by direct DNA sequencing, for loss of alleles on chromosomes 3p and 8, and for methylation abnormalities in the first cloned exon of the von Hippel-Lindau gene.
RESULTS: A missense mutation in the von Hippel-Lindau gene was found in one of the two t(3;8)-associated renal carcinomas. This mutation would produce a stop codon and a truncated protein. Both tumors showed a loss of alleles on the derivative 8 chromosome. When these results were combined with the results of our previous studies, two of the four t(3;8)-associated renal carcinomas, which were examined for molecular genetic changes, showed different von Hippel-Lindau somatic mutations. All renal tumors from the 3;8 translocation family showed loss of the translocated portion of chromosome 3.
CONCLUSIONS: These results support a mechanism of tumorigenesis in the chromosome (3;8) translocation family that involves the loss of both copies of the von Hippel-Lindau gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9166475

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN: 1081-4442


  8 in total

1.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

2.  An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.

Authors:  D Bodmer; M J Eleveld; M J Ligtenberg; M A Weterman; B A Janssen; D F Smeets; P E de Wit; A van den Berg; E van den Berg; M I Koolen; A Geurts van Kessel
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Authors:  H Kanayama ; W O Lui; M Takahashi; T Naroda; D Kedra; F K Wong; Y Kuroki; Y Nakahori; C Larsson; S Kagawa; B T Teh
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

Review 4.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

Review 5.  Advances in the genetics of familial renal cancer.

Authors:  Patrick J Morrison; Deirdre E Donnelly; A Brew Atkinson; Alexander P Maxwell
Journal:  Oncologist       Date:  2010-05-19

6.  Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.

Authors:  E R Woodward; S C Clifford; D Astuti; N A Affara; E R Maher
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

Review 7.  Hereditary kidney cancer: unique opportunity for disease-based therapy.

Authors:  W Marston Linehan; Peter A Pinto; Gennady Bratslavsky; Elizabeth Pfaffenroth; Maria Merino; Cathy D Vocke; Jorge R Toro; Donald Bottaro; Len Neckers; Laura S Schmidt; Ramaprasad Srinivasan
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

8.  Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.

Authors:  W Marston Linehan
Journal:  Genome Res       Date:  2012-10-04       Impact factor: 9.043

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.